Metropolis Healthcare schedules analyst meeting for June 08, 2026
Metropolis Healthcare has scheduled an analyst and institutional investor meeting for June 08, 2026, at 03:30 p.m. IST under the Macquarie Healthcare Tour. The meeting will be a group interaction based on publicly available information, with no unpublished price sensitive information intended to be discussed.

*this image is generated using AI for illustrative purposes only.
Metropolis Healthcare has scheduled an analyst and institutional investor meeting for June 08, 2026, as part of the Macquarie Healthcare Tour. The interaction is set to commence at 03:30 p.m. IST and will be conducted as a group meeting. The company confirmed that discussions during the session will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be shared.
The disclosure was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule was finalized on June 04, 2026, resulting in the intimation being provided at a shorter notice. The company noted that changes to the schedule may occur due to exigencies on the part of the participants, host, or the company.
| Date | Time | Details | Type of Interaction |
|---|---|---|---|
| June 08, 2026 | 03:30 p.m. (IST) onwards | Macquarie Healthcare Tour | Group Meeting |
Historical Stock Returns for Metropolis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.01% | -0.55% | +8.29% | +10.44% | +25.88% | -15.62% |
What key strategic initiatives is Metropolis Healthcare likely to highlight during the Macquarie Healthcare Tour?
How might the insights from this meeting influence investor sentiment towards the healthcare sector?
What potential market impacts could arise from the discussions, given the focus on publicly available information?


































